Cc1nc2c(-c3ccc(Cl)cc3)cnn2c(N)c1-c1ccc(F)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?